Healthcare Realty Trust(DE:HT0)
€17.20+0.32 (+1.87%)
DE:HT0
Healthcare Realty Trust financials statements
€17.20
At close:+0.32 (+1.87%)
Healthcare Realty Trust (HT0) Ratios
1 Followers
Healthcare Realty Trust Ratios
DE:HT0's free cash flow for Q3 2026 was $0.00. For the 2026 fiscal year, DE:HT0's free cash flow was increased by $0.00 and operating cash flow was $0.00. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.75 | 2.35 | 0.90 | 0.68 | 0.46 |
| Quick Ratio | 1.75 | 2.35 | 0.90 | 0.68 | 0.46 |
| Cash Ratio | 0.08 | 0.31 | 0.05 | 0.10 | 0.04 |
| Solvency Ratio | 0.07 | 0.00 | 0.09 | 0.08 | 0.13 |
| Operating Cash Flow Ratio | 1.32 | 2.24 | 0.89 | 0.46 | 0.68 |
| Short-Term Operating Cash Flow Coverage | 3.81 | 0.00 | 1.43 | 0.78 | 1.11 |
| Net Current Asset Value | $ -3.93B | $ -4.82B | $ -5.21B | $ -5.76B | $ -1.92B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.45 | 0.47 | 0.42 | 0.41 | 0.45 |
| Debt-to-Equity Ratio | 0.90 | 0.95 | 0.78 | 0.75 | 0.88 |
| Debt-to-Capital Ratio | 0.47 | 0.49 | 0.44 | 0.43 | 0.47 |
| Long-Term Debt-to-Capital Ratio | 0.45 | 0.47 | 0.41 | 0.40 | 0.42 |
| Financial Leverage Ratio | 2.00 | 2.03 | 1.85 | 1.83 | 1.95 |
| Debt Service Coverage Ratio | 1.60 | 1.04 | 1.24 | 1.34 | 1.24 |
| Interest Coverage Ratio | 0.46 | 0.14 | 0.22 | 0.56 | 1.61 |
| Debt to Market Cap | 0.66 | 0.75 | 0.77 | 0.73 | 0.21 |
| Interest Debt Per Share | 12.44 | 14.27 | 14.64 | 15.41 | 7.22 |
| Net Debt to EBITDA | 7.93 | 18.34 | 7.11 | 8.47 | 5.84 |
| Profitability Margins | |||||
| Gross Profit Margin | -33.58% | -43.79% | 62.27% | 62.56% | 59.53% |
| EBIT Margin | -3.73% | -32.21% | -2.57% | 20.56% | 22.84% |
| EBITDA Margin | 44.04% | 21.02% | 55.93% | 72.55% | 62.21% |
| Operating Profit Margin | 8.04% | 2.87% | 4.09% | 9.01% | 16.33% |
| Pretax Profit Margin | -21.13% | -52.35% | -21.27% | 4.43% | 12.71% |
| Net Profit Margin | -20.84% | -51.60% | -20.98% | 4.45% | 12.71% |
| Continuous Operations Profit Margin | -21.13% | -52.35% | -21.27% | 4.43% | 12.71% |
| Net Income Per EBT | 98.63% | 98.58% | 98.65% | 100.50% | 100.00% |
| EBT Per EBIT | -262.79% | -1823.31% | -520.28% | 49.16% | 77.80% |
| Return on Assets (ROA) | -2.67% | -6.14% | -2.20% | 0.30% | 1.57% |
| Return on Equity (ROE) | -5.33% | -12.50% | -4.08% | 0.54% | 3.05% |
| Return on Capital Employed (ROCE) | 1.07% | 0.35% | 0.45% | 0.62% | 2.19% |
| Return on Invested Capital (ROIC) | 1.06% | 0.35% | 0.44% | 0.61% | 2.08% |
| Return on Tangible Assets | -2.68% | -6.16% | -2.26% | 0.30% | 1.57% |
| Earnings Yield | -4.15% | -10.56% | -4.26% | 0.56% | 0.77% |
| Efficiency Ratios | |||||
| Receivables Turnover | 4.59 | 4.39 | 3.75 | 3.78 | 6.18 |
| Payables Turnover | 0.00 | 0.00 | 0.00 | 6.00 | 12.46 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 5.76 | 4.85 | 4.81 | 2.73 | 4.09 |
| Asset Turnover | 0.13 | 0.12 | 0.10 | 0.07 | 0.12 |
| Working Capital Turnover Ratio | 4.20 | 10.37 | -10.78 | -4.92 | -10.17 |
| Cash Conversion Cycle | 79.52 | 83.19 | 97.33 | 35.74 | 29.76 |
| Days of Sales Outstanding | 79.52 | 83.19 | 97.33 | 96.59 | 59.05 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 0.00 | 0.00 | 0.00 | 60.85 | 29.29 |
| Operating Cycle | 79.52 | 83.19 | 97.33 | 96.59 | 59.05 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 1.31 | 1.37 | 1.32 | 0.72 | 0.85 |
| Free Cash Flow Per Share | 0.36 | 0.69 | 0.71 | 0.29 | 0.48 |
| Dividend Paid and CapEx Coverage Ratio | 0.64 | 0.71 | 0.71 | 0.17 | 0.84 |
| Capital Expenditure Coverage Ratio | 1.38 | 2.01 | 2.16 | 1.67 | 2.31 |
| Operating Cash Flow Coverage Ratio | 0.11 | 0.10 | 0.09 | 0.05 | 0.12 |
| Operating Cash Flow to Sales Ratio | 0.39 | 0.40 | 0.38 | 0.30 | 0.44 |
| Free Cash Flow Yield | 2.14% | 4.08% | 4.12% | 1.49% | 1.53% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -23.87 | -9.36 | -23.46 | 178.92 | 129.79 |
| Price-to-Sales (P/S) Ratio | 5.02 | 4.89 | 4.92 | 7.96 | 16.49 |
| Price-to-Book (P/B) Ratio | 1.28 | 1.18 | 0.96 | 0.97 | 3.96 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 46.71 | 24.53 | 24.29 | 67.00 | 65.57 |
| Price-to-Operating Cash Flow Ratio | 12.97 | 12.35 | 13.06 | 26.83 | 37.19 |
| Price-to-Earnings Growth (PEG) Ratio | 0.39 | -0.06 | -0.14 | -0.28 | -3.21 |
| Enterprise Value Multiple | 19.33 | 41.58 | 15.91 | 19.44 | 32.36 |
| Enterprise Value | 10.05B | 11.09B | 11.80B | 12.96B | 10.56B |
| EV to EBITDA | 19.33 | 41.58 | 15.91 | 19.44 | 32.36 |
| EV to Sales | 8.51 | 8.74 | 8.90 | 14.10 | 20.13 |
| EV to Free Cash Flow | 79.17 | 43.88 | 43.91 | 118.69 | 80.03 |
| EV to Operating Cash Flow | 21.99 | 22.10 | 23.61 | 47.52 | 45.39 |
| Tangible Book Value Per Share | 13.31 | 14.42 | 17.43 | 19.43 | 7.96 |
| Shareholders’ Equity Per Share | 13.20 | 14.32 | 18.01 | 19.94 | 7.99 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 3.37 | 3.47 | 3.50 | 2.42 | 1.92 |
| Net Income Per Share | -0.70 | -1.79 | -0.73 | 0.11 | 0.24 |
| Tax Burden | 0.99 | 0.99 | 0.99 | 1.01 | 1.00 |
| Interest Burden | 5.67 | 1.63 | 8.27 | 0.22 | 0.56 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 0.00 | 0.04 | 0.06 | 0.07 |
| Stock-Based Compensation to Revenue | 0.02 | 0.03 | 0.01 | 0.02 | 0.02 |
| Income Quality | -1.86 | -0.76 | -1.77 | 6.70 | 3.49 |
Currency in USD
